Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Cash Flow from Financial Activities of $-17.40M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$126.44M |
|
$0.82M |
|
$80.85M |
|
$45.59M |
|
$113.57M |
|
$12.87M |
|
$-5.88M |
|
$6.99M |
|
$6.99M |
|
$1.48M |
|
$1.48M |
|
$1.03M |
|
$1.48M |
|
$12.87M |
|
$21.36M |
|
636.45M |
|
658.25M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$626.07M |
|
$335.43M |
|
$806.41M |
|
$1.43B |
|
$453.07M |
|
$389.29M |
|
$453.94M |
|
$907.02M |
|
$525.47M |
|
$329.37M |
|
$525.47M |
|
638.67M |
|
| Cash Flow Statement Financials | |
$20.09M |
|
$-14.82M |
|
|
Cash Flow from Financial Activities |
$-17.40M |
$160.43M |
|
$152.69M |
|
$-7.74M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
0.43 |
|
1.01 |
|
36.05% |
|
10.18% |
|
10.18% |
|
-- |
|
5.53% |
|
0.65% |
|
$13.44M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.69 |
|
0.41 |
|
216.90 |
|
0.28% |
|
0.45% |
|
0.10% |
|
0.16% |
|
$0.82 |
|
$0.02 |
|
$0.03 |
|